Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) traded down 5.7% during mid-day trading on Friday . The company traded as low as $7.04 and last traded at $7.17. 471,407 shares traded hands during trading, a decline of 15% from the average session volume of 551,962 shares. The stock had previously closed at $7.60.
Cybin Stock Down 5.7%
The stock has a fifty day moving average of $7.88 and a 200-day moving average of $7.68. The stock has a market cap of $1.07 billion and a PE ratio of -29.88.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
- Five stocks we like better than Cybin
- How to Profit From Growth Investing
- 3 Restaurant Stocks That Will Outperform in Q3 and Q4
- Trading Stocks: RSI and Why it’s Useful
- The Midstream Energy Play That Keeps Powering Higher
- Conference Calls and Individual Investors
- Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
